Dr. Moshe Torem shares his 30+ years of experience and discusses the difference between bipolar and non-bipolar mood swings, along with common causes of non-bipolar mood swings. For more information about the Integrated Care @ NEOMED (IC@N) ECHO program, visit https://libraryguides.neomed.edu/ICAN…The information shared during this presentation solely represent the opinions and expertise of the presenter and are not those of Northeast Ohio Medical University unless expressly stated otherwise.
Tag: antipsychotic
Long-Acting Injectable Antipsychotic Medications: Recent Findings
Dr. Smith discusses the most up-to-date information on the use of long-acting injectables for the treatment of psychosis in May 2021. For more information about the Integrated Care @ NEOMED (IC@N) ECHO program, visit https://libraryguides.neomed.edu/ICAN…The information shared during this presentation solely represent the opinions and expertise of the presenter and are not those of Northeast Ohio Medical University unless expressly stated otherwise.
Hyperprolactinemia: The medications that can cause it and what can be done about it.
In this lecture, Dr. Dugan discusses medications that commonly cause hyperprolactinemia and presents options for management. By the end of this lecture, you will be able to: 1) list the causes of elevated prolactin levels, 2) identify symptoms associated with elevated prolactin levels, and 3) compare the impact medications commonly used for mental health conditions have on prolactin levels.
Nicotine: Is It Good or Bad for People with Schizophrenia?
In this lecture, Dr. Dugan discusses the impact of nicotine on schizophrenia. By the end of this lecture, you will be able to: 1) describe the actions of nicotine on neurotransmitters, 2) list potential reasons for high use of nicotine products, specifically cigarettes in patients with schizophrenia, and 3) identify evidence of nicotine’s actions in patients with schizophrenia.
Drug Interactions with Psychiatric Medications
In this lecture, Dr. Dugan covers the basics of drug metabolism and highlights several important psychiatric drug-drug interactions that patients as well as prescribers should be aware of. By the end of this lecture, you will be able to: 1) compare pharmacodynamic and pharmacokinetic drug interactions and 2) identify relevant drug interactions with medications used in the treatment of mental illnesses.
Metformin in Psychiatric Practice
In this lecture, Dr. Dugan briefly reviews the pharmacology of metformin and describes studies that look at the potential uses for metformin in psychiatric practice. By the end of this lecture, you will be able to: 1) describe the pharmacology of metformin, 2) identify potential uses of metformin in the mental health field, and 3) outline a monitoring plan for patients on metformin.
Antipsychotics
In this lecture, Dr. Dugan addresses the proper dosing of antipsychotic medication. By the end of this lecture, you will be able to: 1) identify biological, social, and psychological factors that affect psychotic illness, 2) define the mechanisms or rationale for treatments appropriate for psychotic illness, and 3) integrate biological, social, and psychological considerations when designing and implementing treatment of individuals affected by psychotic illness.
Pharmacodynamics: How do antipsychotic medications work?
In this lecture, Dr. Dugan reviews the mechanisms of action of the medications used to treat psychosis. By the end of this lecture, you will be able to: 1) identify common pharmacologic targets of first and second generation antipsychotic medications, 2) describe proposed therapeutic actions of first and second generation antipsychotic medications, and 3) compare adverse effect profiles of the first and second generation antipsychotic medications.
